AMLN: It will be interesting to see what develops re potential buy-out: http://www.bloomberg.com/news/print/2012-05-15/amylin-said-to-attract-interest-from-pfizer-astrazeneca.html No mention of buy-out in Q&A at ASM today. AMLN trading at a 52 week high.